IL17A and diabetic kidney disease: Although little is known about the potential effect of IL-17 on glomerular basement membrane (GBM), the IL 17 presence was associated with GBM thickening in a model of accelerated diabetic nephropathy; while IL-17A blockade with antibody reduced this effect (144).